Availability of information in relation to the 2026 General Meeting

Paris, 3 April 2026 - Clariane (CLARI - ISIN: FR0010386334) informs its shareholders that a Combined General Meeting (the "General Meeting") of the Company will take place on 12 May 2026 at 2 p.m. in the meeting room Apostrophe, located at 83 avenue Marceau, 75016 Paris.

The prior notice of the General Meeting containing the agenda, the draft resolutions presented by the Board of Directors and the description of the participation and voting arrangements for the General Meeting, was published in the Bulletin des Annonces Légales Obligatoires no. 40 of 3 April 2026.

The information regarding the General Meeting mentioned in Article R. 22-10-23 of the French Commercial Code can be found on the Company's website at the following address: https://www.clariane.com, in the "Investors" section, under "Shareholders", "General meetings" and then "2026".

Shareholders will also be able to consult the documents at the Company's registered office located at 21-25, rue Balzac, 75008 Paris, France during the 15 days preceding the holding of the General Meeting.

Clariane is the leading European community for care in times of vulnerability. It has operations in six countries: Belgium, France, Germany, Italy, the Netherlands and Spain.

The Group relies on the diverse expertise of its 65,000 staff members, who each year provide services to nearly 850,000 patients and residents in two main areas of activity: "Long-term care" and "Specialty care".

In June 2023, Clariane became a purpose-driven company and added a new corporate purpose, common to all its activities, to its articles of association: "To take care of each person's humanity in times of vulnerability".

Clariane has been listed on Euronext Paris, Section B since November 2006. The Group joined the SBF 120 index and the CAC® SBT 1.5° index on 23 September 2024.

Euronext ticker: CLARI - ISIN: FR0010386334

Press release - 3 April 2026 2/2